Micro Imaging Technology

Micro Imaging Technology Current Liabilities

The Current Liabilities of Micro Imaging Technology (MMTC) as of Sep 19, 2026 is 1.18 M USD. In the previous year, Current Liabilities was 690,800.00 USD — a change of 71.13% (higher).

Current Liabilities

1.18 MUSD

YoY

71.13%

Last updated:

Current Liabilities of Micro Imaging Technology is 2026 1.18 M USD. Current Liabilities of Micro Imaging Technology was 2025 690,800.00 USD. It decreases by 71.13% higher compared to the previous year.

The Micro Imaging Technology Current Liabilities history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Current Liabilities
Date
Current Liabilities
Jan 1, 2007
510,000.00 USD
Jan 1, 2008
731,000.00 USD
Jan 1, 2009
908,300.00 USD
Jan 1, 2010
1.74 M USD
Jan 1, 2011
2.38 M USD
Jan 1, 2012
690,800.00 USD
Jan 1, 2013
1.18 M USD
The Micro Imaging Technology Current Liabilities history
YEARCurrent LiabilitiesYoY
1.18 MUSD+71.13%
690,800.00USD-70.99%
2.38 MUSD+36.61%
1.74 MUSD+91.90%
908,300.00USD+24.25%
731,000.00USD+43.33%
510,000.00USD
Access this data via the Eulerpool API

Micro Imaging Technology Stock analysis

What does Micro Imaging Technology do? Micro Imaging Technology Inc (MIT) is a US-based company specializing in the development and marketing of innovative visual technologies for the food industry and healthcare. The company was founded in 2003 and is headquartered in San Clemente, California. MIT's business model is based on the use of its patented technology for the rapid and reliable identification of microbes in food and beverages. The company offers various products and services, including the MIT System for bacteria identification, the Pathex System for pathogen identification, and the QwikChek System for rapid testing of contaminated food and beverages. MIT operates in two divisions: the food and beverage industry and healthcare. In the food and beverage industry, the company provides innovative solutions for the rapid and reliable identification of bacteria and other microorganisms. In healthcare, MIT offers solutions for the rapid and reliable identification of disease-causing bacteria and other microorganisms. The core technology product of MIT is the MIT System for bacteria identification, which combines computer-based image analysis and specialized software to enable the identification of bacteria within minutes. The Pathex System is a rapid and accurate method for identifying pathogens in clinical samples. The QwikChek System is a fast test used for identifying contaminated food and beverages. MIT has developed an innovative business model based on its patented technology for the rapid and reliable identification of microbes in food and beverages. The company operates in two divisions: the food and beverage industry and healthcare. Micro Imaging Technology is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Micro Imaging Technology stock

Current Liabilities of Micro Imaging Technology is 1.18 M USD in 2026.

Current Liabilities of Micro Imaging Technology changed from 690,800.00 USD to 1.18 M USD, representing a 71.13% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Current Liabilities Micro Imaging Technology since 2006 – with annual values, charts, and detailed analysis.

Current liabilities are obligations due within one year, including accounts payable, short-term debt, and accrued expenses.

Current Liabilities's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Current Liabilities's Micro Imaging Technology historically and in real time.

Access this data via the Eulerpool API

Balance Sheet — Micro Imaging Technology

All Key Metrics — Micro Imaging Technology